Conference contributions

         Conference contributions presented by B. Lundström-Stadelmann

  1. Keynote: Lundström-Stadelmann B. Metabolism in Parasitic Helminths, Seminar day and user meeting on live-cell metabolic profiling, Bucher Biotec, Bern, Oct. 16, 2024.
  2. Invited Talk: Lundström-Stadelmann B. The quest for new compounds for the treatment of alveolar echinococcosis, Conference on Tropical Medicine and Global Health, Düsseldorf, Germany, Sept 19-21, 2024.
  3. Invited Talk: Lundström-Stadelmann B. Novel drug treatments against alveolar echinococcosis, what is going on in vitro and in mouse models. Swiss Echinococcosis network, online meeting, Apr. 16, 2024.
  4. Invited Talk: Lundström-Stadelmann B and Frey C. Top-Sharing. IDEAS Retreat. Ticino, Aug 28, 2023.
  5. Invited Talk: Lundström-Stadelmann B and Frey C. Geschichten des Gelingens – Gleichstellungsmassnahmen von Hochschulen im Dialog. University of Bern, Mar. 8, 2023.
  6. Chaudhry, S., Zurbriggen, R., Preza, M., Kämpfer, T., Kaethner, M., Memedovski, R., Scorrano, N., Hemphill, A., Doggett, J.S., Lundström-Stadelmann, B. Dual inhibition of the Echinococcus multilocularis energy metabolism. International Conference of Parasitology (ICOPA), Copenhagen, DNK, Aug. 21-26, 2022.
  7. Invited Presentation: Lundström-Stadelmann B. Novel approaches for the treatment of alveolar echinococcosis. Meeting of the Swiss Network of Echinococcosis, online, May 16, 2022.
  8. Invited Presentation: Lundström-Stadelmann B. Novel approaches for the treatment of the fox tapeworm Echinococcus multilocularis. Mini symposium on the occasion of the retirement of Prof. Peter Deplazes, University of Zürich, Jan 20, 2022.
  9. Invited Presentation: Lundström-Stadelmann B. Novel approaches for the treatment of the fox tapeworm Echinococcus multilocularis. Seminar on Drug Sciences. University of Basel, online, Nov 3, 2021.
  10. Invited Presentation: Lundström-Stadelmann B. Novel treatment options against echinococcosis. Joint annual meeting 2021 of the Swiss Societies for Infectious Diseases (SSI), Hospital Hygiene (SSHH) with fibs/SIPI, Tropical Medicine and Parasitology (SSTMP) and the Swiss Society of Tropical and Travel Medicine (SSTTM), Montreux, CH, Sept. 2/3, 2021.
  11. Invited Presentation: Lundström-Stadelmann B and CF Frey. Impulsreferat zum Topsharing an der Universität Bern, University of Bern, CH, online, Mar. 8, 2021.
  12. Lundström-Stadelmann, B. Invited Presentation: Mefloquine and derivatives against Echinococcus multilocularis. Anthelmintics IV meeting, Santa Monica Bay, CA, Feb. 6, 2020.
  13. Invited Presentation: Lundström-Stadelmann B. Mefloquine and derivatives against Echinococcus multilocularis. Anthelmintics IV meeting, Santa Monica Bay, CA, Feb. 6, 2020.
  14. Invited seminar on new appraoches in anti-infective therapy: Lundström-Stadelmann B. Novel drug treatments against parasites: the example of Echinococcus multilocularis, University of Rennes, F, Nov. 28, 2019.
  15. Ritler, D., Rufener, R., Li, J.V., Kämpfer, U., Bühr, C., Schürch, S., Lundström-Stadelmann, B. Identification of novel drug targets in Echinococcus multilocularis by metabolomics. Drug Design and Development Seminar (DDDS), Justus-Liebig Universität Giessen, Germany, Mar. 26-29, 2019.
  16. Seminar on new approaches in anti-infective therapy: Lundström-Stadelmann B. To live or let die: novel chemotherapeutical treatments against the parasitic disease alveolar echinococcosis, University of Rennes, F, Nov. 22, 2018.
  17. Presentation for interview Professor in Parasitology: Helminth control: from the field to the molecule and back, Vetsuisse Bern, CH, May 31, 2018.
  18. Lundström-Stadelmann B. To live or let die: novel treatments against parasitic diseases. Habilitation lecture, Vetsuisse Faculties Bern and Zürich, Bern, Switzerland, Mar. 15, 2018.
  19. Ritler, D., Rufener, R., Li, J., Lundström-Stadelmann, B.. The metabolism of Echinococcus multilocularis. World Congress in Echinococcosis, Algiers, ALG, Oct. 4-7, 2017.
  20. Lundström-Stadelmann, B., Rufener, R., Dick, L., Gorgas, D., Marreros, N., Joekel, D., Küster, T., de Souza, M.V.N., Hemphill, A. Activity of the anti-malarial mefloquine against Echinococcus. World Congress in Echinococcosis, Algiers, ALG, Oct. 4-7, 2017.
  21. Rufener, R., Dick, L., Strübig, L., Hemphill, A., Lundström-Stadelmann, B. An old drug reused: the activity of buparvaquone against the fox tapeworm Echinococcus multilocularis. Joint annual meeting SSM, SSI, SSHH, SSTMP and SSTTM, Basel, CH, Aug. 30 – Sept. 1, 2017.
  22. Stadelmann, B., and A. Hemphill. Present status of alternative treatment of human and murine AE. Treatment and follow-up of AE in human patients, Bern, CH, Feb. 11, 2016.
  23. Stadelmann, B. Plenary talk: Repurposed drugs and novel drug targets for the treatment of echinococcosis. 16th World Congress in Echinococcosis, Bukarest, ROU, Oct. 1-3, 2015.
  24. Stadelmann, B., Rufener, R., Spiliotis, M., Kunz, S., Aeschbacher, D., Müller, J., and A. Hemphill. A novel anti-malarial compound with promising activity against Echinococcus multilocularis interacts directly with Echinococcus calmodulin. 16th World Congress in Echinococcosis, Bukarest, ROU, Oct. 1-3, 2015.
  25. Stadelmann, B., Aeschbacher, D., Huber, C., Spiliotis, M., Müller, J. and A. Hemphill. Profound activity of the anti-cancer drug bortezomib against E. multilocularis metacestodes identifies the proteasome as a novel drug target in cestodes. Joint meeting DGP und SGTP. Zürich, CH, Jul. 16-19, 2014.
  26. Stadelmann, B., Aeschbacher, D., Huber, C., Spiliotis, M., Müller, J. and A. Hemphill. Inhibition of E. multilocularis by Bortezomib – The proteasome as a novel target in cestodes. Innovation for the Management of Echinococcosis. Besançon, FRA, Mar. 27-29, 2014. (poster prize)
  27. Stadelmann, B., Maayeh‘, S., Hoeppner, M.P., Eteti, C.M., Andersson, M.K., Ankarklev, J., Zamani, N., Grabherr M. and S.G. Svärd. Transcriptional changes of human intestinal epithelial cells upon infection with the parasite Giardia intestinalis reveal the role of NFKB and AU-rich elements in the early onset of giardiasis. 5th international Giardia and Cryptosporidium conference. Uppsala, SWE, May 27-30, 2014.
  28. Invited seminar: The role of arginine in Giardia infection. Institute of Parasitology, University of Bern, CH, Aug. 2012.
  29. Stadelmann, B., Jerlström-Hultqvist J., Merino C., Ankarklev J., Einarsson E. and S. Svärd. The role of arginine during Giardia infection.  IV International Cryptosporidium & Giardia Conference. Wellington, NZ, Jan. 31-Feb. 3, 2012.
  30. Stadelmann, B. The role of arginine in giardiasis. Protozoa meeting. Uppsala, SWE, Dec. 12, 2011.
  31. Invited seminar: To be or not to be: The importance and applications of EmPGI in alveolar echinococcosis, Swiss Society of Tropical Medicine and Parasitology (SSTMP), annual meeting, Basel, CH, Nov. 2011.
  32. Invited seminar: Echinococcus multilocularis (rävens dvärgbandmask) and alveolar echinococcosis. Swedish Institute for Infectious Disease Control (SMI), Stockholm, SWE, Nov. 2011.
  33. Invited seminar: Echinococcus multilocularis and alveolar echinococcosis in Switzerland. Swedish Veterinary Agency (SVA), Uppsala, SWE, Feb. 2011.
  34. Stadelmann, B., Jerlström-Hultqvist, J. and S. Svärd. Arginine deiminase and ornithine carbamoyl transferase as pathogenicity factors in giardiasis. SGTP meeting, Spiez, CH, Oct. 28/29, 2010.
  35. Stadelmann, B., Scholl, S., Küster, T., Müller, J. and A. Hemphill. Small scale in vitro screening for new compounds against Echinococcus multilocularis. ICOPA XII, Melbourne, AUS, Aug. 15-20, 2010.
  36. Stadelmann, B., Scholl, S., Küster, T., Müller, J. and A. Hemphill. Small scale in vitro screening for new compounds against Echinococcus multilocularis. DGP meeting, Düsseldorf, DEU, Mar. 16-19, 2010.
  37. Stadelmann, B., Gottstein, B. and A. Hemphill. The host-parasite interface of alveolar echinococcosis and phosphoglucose isomerase (PGI). DGP meeting, Hamburg, DEU, Mar. 5-7, 2008.
  38. Stadelmann, B., Deutsch, U., Gottstein, B. and A. Hemphill. Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a moonlighting enzyme? SGTP meeting, Vevey, CH, Oct. 23-25, 2008.
  39. Stadelmann, B., Scholl, S., Müller, J. and A. Hemphill. Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a moonlighting enzyme? PhD Symposium, Bern, CH, Jan. 28, 2009.
  40. Stadelmann, B., Naguleswaran, A., Gottstein, B., Hemphill, A. The laminated layer of Echinococcus multilocularis and phosphoglucose isomerase (PGI): studies on the host-parasite interface. 22nd International Congress on hydatidology, Athens Hilton, GRC, May 15-19, 2007.
  41. Stadelmann, B., Hemphill, A. Characterization of laminated layer protein in Echinococcus multilocularis metacestodes. Annual meeting of the Swiss Society of Tropical Medicine and Parasitology. Swiss Tropical Institute, Basel, CH, Sept. 22-23, 2006.

 

 

 

            Conference contributions presented by group members and/or collaborators

  1. Wiedemar N, Gliga DS; Galat M, Preza M, Kaethner M, Frey CF, Lundström-Stadelmann B. Tools for investigation of drug resistance and screening of new compounds in the liver fluke Fasciola hepatica. 24th Drug Design & Development Seminar (DDDS) of the German Society for Parasitology, Würzburg, GER, Mar. 12-15, 2024. (P)
  2. Preza M, Hiller L, Dietrich N, Lundström-Stadelmann B. Niclosamide ethanolamine against the fox tapeworm, Echinococcus multilocularis. 24th Drug Design & Development Seminar (DDDS) of the German Society for Parasitology, Würzburg, GER, Mar. 12-15, 2024. (P)
  3. Benazzouz S, Kaethner M, Preza M, Kaempfer T, Zumstein P, Tamponi C, Varcasia A, Hemphill A, Brehm K, Lundström-Stadelmann B. In vitro drug screening cascade for Echinococcus granulosus. 24th Drug Design & Development Seminar (DDDS) of the German Society for Parasitology, Würzburg, GER, Mar. 12-15, 2024.
  4. Bartetzko A, Zumstein P, Preza M, Lundström-Stadelmann B. Response to alveolar echinococcosis: Screening of the MMV Pandemic Response Box revealed a novel promising compound. 24th Drug Design & Development Seminar (DDDS) of the German Society for Parasitology, Würzburg, GER, Mar. 12-15, 2024. (P)
  5. Zumstein P, Bartetzko A, Preza M, Nyffeler C, Mathis D, Lundström-Stadelmann B. Investigation of the malate dismutation pathway as a potential drug target in Echinococcus mutlilocularis. 24th Drug Design & Development Seminar (DDDS) of the German Society for Parasitology, Würzburg, GER, Mar. 12-15, 2024. (P)
  6. Kaempfer T, Preza M, Hayoz M, Aebi Y, Kaethner M, Zumstein P, Largiader C, Brehm K, Lundström-Stadelmann B. Assessment of triclabendazole treatment against E. multilocularis. 24th Drug Design & Development Seminar (DDDS) of the German Society for Parasitology, Würzburg, GER, Mar. 12-15, 2024.
  7. Kaethner M, Zumstein P, Przea M, Bartetzko A, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Lundström-Stadelmann B. Investigation of the threonine metabolism of Echinococcus multilocularis: EmTDH as a potential drug target against alveolar echinococcosis. 24th Drug Design & Development Seminar (DDDS) of the German Society for Parasitology, Würzburg, GER, Mar. 12-15, 2024.
  8. Bartetzko A, Zumstein P, Preza M, Lundström-Stadelmann B. Screening of the MMV Pandemic Response Box against Echinococcus multilocularis reveals novel potential chemotherapeutics. Bern Parasitology Meeting, Bern, Feb. 2, 2024. (P)
  9. Zumstein P, Bartetzko A, Preza M, Nyffeler C, Mathis D, Lundström-Stadelmann B. Investigation of the malate dismutation pathway as a potential drug target in Echinococcus mutlilocularis. Bern Parasitology Meeting, Bern, Feb. 2, 2024. (P)
  10. Bartetzko A, Zumstein P, Preza M, Nyffeler C, Mathis D, Lundström-Stadelmann B. Cutting off the oxygen: Metabolic changes and differential gene expression depending on oxygen condition in E. multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Schwarzenberg, CH, Nov. 9/10, 2023. *** Best-presentation award***
  11. Kaempfer T, Lundström-Stadelmann B. In vitro culture and treatment of Taenia crassiceps metacestodes. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Schwarzenberg, CH, Nov. 9/10, 2023.
  12. Galat M, Moré G, Mikharovskyi G, Malyuk M, Ovchinnikova A, Kovalenko G, Joeres M, Schares G, Lundström-Stadelmann B, Frey CF. The first Toxoplasma gondii genotyping from sheep slaughtered for human consumption in Ukraine. Annual meeting of the Swiss Society of Tropical Medicine, Basel, CH, Sept. 7/8, 2023.
  13. Preza M, Kaethner M, Kaempfer T, Zumstein P, Tamponi C, Varcasia A, Hemphill A, Brehm K, Lundström-Stadelmann B. Advancing in drug discovery against Echinococcus granulosus sensu stricto: development and utilization of impartial in vitro screening assays. Annual meeting of the Swiss Society of Tropical Medicine, Basel, CH, Sept. 7/8, 2023.
  14. Wiedemar N, Gliga DS, Preza M, Galat M, Kaethner M, Frey CF, Lundström-Stadelmann B. Triclabendazole resistance in Swiss Fasciola hepatica. Annual meeting of the Swiss Society of Tropical Medicine, Basel, CH, Sept. 7/8, 2023. (P)
  15. Kaethner M, Zumstein P, Preza M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Lundström-Stadelmann B. Investigation and inhibition of the threonine metabolism of Echinococcus multilocularis. Annual meeting of the Swiss Society of Tropical Medicine, Basel, CH, Sept. 7/8, 2023.
  16. Zumstein P, Bartetzko A. Preza M, Kaethner M, Scorrano N, Kämpfer T, Lundström-Stadelmann B. Screening of the MMV Pandemic Response Box agianst Echinococcus multilocularis reveals novel potential chemotherapeutics. Annual meeting of the Swiss Society of Tropical Medicine, Basel, CH, Sept. 7/8, 2023. (P)
  17. Kaempfer T, Preza M, Scorrano N, Kaethner M, Hayoz M, Aebi Y, Largiader C, Brehm K, Lundström-Stadelmann B. Assessment of triclabendazole treatment against E. multilocularis. XXIX World Congress of Echinococcosis, Bishkek, KYR, Aug. 28-30, 2023.
  18. Preza M, Kaethner M, Kaempfer T, Zumstein P, Tamponi C, Varcasia A, Hemphill A, Brehm K, Lundström-Stadelmann B. Advancing in drug discovery against Echinococcus granulosus sensu stricto: development and utilization of impartial in vitro screening assays. XXIX World Congress of Echinococcosis, Bishkek, KYR, Aug. 28-30, 2023.
  19. Kaempfer T, Gliga DS, Wiesner M, Basso W, Lundström-Stadelmann B. In vitro culture and treatment of Taenia crassiceps metacestodes. European Veterinary Parasitology College, Paris, F, June 30, 2023. (P)
  20. Kaethner M, Zumstein P, Preza M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez, Lundström-Stadelmann B. Investigation and inhibition of the threonine metabolism of Echinococcus multilocularis. GCB Symposium University of Bern, CH, June 29, 2023.
  21. Kaempfer T, Preza T, Scorrano N, Kaethner M, Hayoz M, Aebi Y, Largiader C, Brehm K, Lundström-Stadelmann B. Assessment of triclabendazole treatment against E. multilocularis. GCB Symposium University of Bern, CH, June 29, 2023. (P)
  22. Kaethner M, Preza M, Kaempfer T, Zumstein P, Tamponi C, Varcasia A, Hemphill A, Brehm K, Lundström-Stadelmann, B. Objective in vitro drug testing for Echinococcus granulosus. 30th annual meeting of the German Society for Parasitology, DE, Mar. 15-17, 2023.
  23. Kaethner M, Zumstein P, Preza M, Grossenbacher, P, Lochner, M, Schürch, S, Regnault, C, Villalobos Ramirez, D, Lundström-Stadelmann, B. The Achilles’ heel of the fox tapeworm? - Investigation of the threonine metabolism of Echinococcus multilocularis. 30th annual meeting of the German Society for Parasitology, DE, Mar. 15-17, 2023.
  24. Zumstein P, Preza M, Kaethner M, Kaempfer T, Lundström-Stadelmann B. Screening of the MMV Pandemic Response Box against E. multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Bern, CH, Nov. 9, 2022.
  25. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Zumstein P, Lundström-Stadelmann B. Starving a deadly parasite: Investigation and inhibition of the threonine metabolism of the fox tapeworm Echinococcus multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Bern, CH, Nov. 9, 2022.
  26. Kämpfer T, Przea M, Scorrano N, Kaethner M, Hayoz M, Yebi Y, Largiader C, Brehm K, De Brot S., Lundström-Stadelmann, B. Assessment of triclabendazole treatment against E. multilocularis. Joint annual conference of the Swiss Society of Tropical Medicine and Swiss Society of Tropical and Travel Medicine, Bern, CH, Nov. 10/11, 2022.
  27. Preza M, Kaethner M, Kaempfer T, Tamponi C, Varcasia A, Lundström-Stadelmann B. In vitro drug screening against Echinococcus multilocularis and E. granulosus. Joint annual conference of the Swiss Society of Tropical Medicine and Swiss Society of Tropical and Travel Medicine, Bern, CH, Nov. 10/11, 2022.
  28. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Zumstein P, Lundström-Stadelmann B. Hungry for threonine: metabolomics in Echinococcus multilocularis. Joint annual conference of the Swiss Society of Tropical Medicine and Swiss Society of Tropical and Travel Medicine, Bern, CH, Nov. 10/11, 2022.
  29. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Lundström-Stadelmann B. The Achilles’ heel of the fox tapeworm? Investigation of the threonine metabolism of Echinococcus multilocularis. Parasitic Helminths: New Perspectives in Biology and Infection, Hydra, GRC, Aug. 28-Sept. 2, 2022. (P)
  30. Kaethner M, Preza M, Kämpfer T, Tamponi C, Varcasia A, Lundström-Stadelmann B. In vitro drug screening cascade for Echinococcus granulosus. International Conference of Parasitology (ICOPA), Copenhagen, DNK, Aug. 21-26, 2022. (P)
  31. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Lundström-Stadelmann B. The Achilles’ heel of the fox tapeworm? Investigation of the threonine metabolism of Echinococcus multilocularis. International Conference of Parasitology (ICOPA), Copenhagen, DNK, Aug. 21-26, 2022. (P)
  32. Preza M, Kaethner M, Kämpfer T, Scorrano N, Lundström-Stadelmann B. The metabolism of Echinococcus multilocularis under new drug testing. International Conference of Parasitology (ICOPA), Copenhagen, DNK, Aug. 21-26, 2022. (P)
  33. Stettler M, Lotz C, Probst A, Hofmann D, Marreros N, Hofer A, Lundström-Stadelmann B, Frey CF, Keiser J,  Hoby S. Pharmacokinetics of praziquantel in European pond turtles (Emys orbicularis). Zoo and Wildlife Conference, Emmen, NL, May 24-28, 2022.
  34. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Lundström-Stadelmann B. The Achilles’ heel of the fox tapeworm? Investigation of the threonine metabolism of Echinococcus multilocularis. GCB Symposium, online, Bern, Jan 27, 2022. (P)
  35. Kämpfer T, Preza M, Chaudhry S, Kaethner M, Scorrano N, Lundström-Stadelmann B. Albendazole against E. multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Schwarzenberg, CH, Oct. 21/22, 2021.
  36. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Lundström-Stadelmann B. The Achilles’ heel of the fox tapeworm? Investigation of the threonine metabolism of Echinococcus multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Schwarzenberg, CH, Oct. 21/22, 2021.
  37. Autier B, Manuel C, Lundström-Stadelmann B, Girard J-P, Gottstein B, Samson M, Robert-Gangneux F, Dion S. IL-33 has a detrimental role in the progression of alveolar echinococcosis in a mouse model. European Mulicolloqium of Parasitology (EMOP), Belgrade, SRB, Oct. 12-16, 2021. (P)
  38. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Villalobos Ramirez D, Lundström-Stadelmann B. The Achilles’ heel of the fox tapeworm? Investigation of the threonine metabolism of Echinococcus multilocularis. European Mulicolloqium of Parasitology (EMOP), Belgrade, SRB, Oct. 12-16, 2021.
  39. Chaudhry S, Zurbriggen R, Doggett S, Lundström-Stadelmann B. Dual inhibition of the Echinococcus multilocularis energy metabolism. European Mulicolloqium of Parasitology (EMOP), Belgrade, SRB, Oct. 12-16, 2021.
  40. Memedovski R, Rufener R, Zurbriggen R, Braga S, Heller M, Müller J, Vinicius Nora de Souza M, Lundström-Stadelmann B. Activity and mechanism of action of meflqouine derivatives against Echinococcus. European Mulicolloqium of Parasitology (EMOP), Belgrade, SRB, Oct. 12-16, 2021.
  41. Invited presentation: Memedovski R, Rufener R, Chaudhry S, Kaethner M, Müller J, Lundström-Stadelmann B. Asessment of mitochondrial respiration in Echinococcus multilocularis germinal layer cells by Seahorse Mini Analyzer. Seahorse Seminar Day and User Meeting, Bucher Biotech, Sept. 22, 2021.
  42. Chaudhry S, Zurbriggen R, Dogget S, Lundström-Stadelmann B. Dual inhibition of the Echinococcus multilocularis energy metabolism. Joint annual meeting 2021 of the Swiss Societies for Infectious Diseases (SSI), Hospital Hygiene (SSHH) with fibs/SIPI, Tropical Medicine and Parasitology (SSTMP) and the Swiss Society of Tropical and Travel Medicine (SSTTM), Montreux, CH, Sept. 2/3, 2021.
  43. Kaethner M, Grossenbacher P, Lochner M, Schürch S, Regnault C, Ramírez DV, Lundström-Stadelmann B. The Achilles’ heel of the fox tapeworm? Investigation of the threonine metabolism of Echinococcus multilocularis. Joint annual meeting 2021 of the Swiss Societies for Infectious Diseases (SSI), Hospital Hygiene (SSHH) with fibs/SIPI, Tropical Medicine and Parasitology (SSTMP) and the Swiss Society of Tropical and Travel Medicine (SSTTM), Montreux, CH, Sept. 2/3, 2021.
  44. Memedovski R, Rufener R, Müller J, Zurbriggen R, de Sousa MVN, Braga S, Heller S, Lundström-Stadelmann B. Mefloquine based analogs evaluated against Echinococcus multilocularis metacestodes. Joint annual meeting 2021 of the Swiss Societies for Infectious Diseases (SSI), Hospital Hygiene (SSHH) with fibs/SIPI, Tropical Medicine and Parasitology (SSTMP) and the Swiss Society of Tropical and Travel Medicine (SSTTM), Montreux, CH, Sept. 2/3, 2021.
  45. Memedovski R, Rufener R, Müller J, Zurbriggen R, de Sousa M, Lundström-Stadelmann B. Mefloquine based analogs evaluated against Echinococcus multilocularis metacestodes. Swiss Society of Tropical Medicine and Parasitology Students Meeting, online, CH, Nov. 4/5, 2020.
  46. Karpstein T, Rufener R, Zurbriggen R, Bresson-Hadni S, Aebi Y and team, Hemphill A, Lundström-Stadelmann B. Is Maca the next super drug against alveolar echinococcosis? Or A reverse approach starting with a cured patient. Swiss Society of Tropical Medicine and Parasitology Students Meeting, online, CH, Nov. 4/5, 2020.
  47. Kaethner M, Schürch S, Lundström-Stadelmann B. Starving a deadly parasite: Investigation and inhibition of the threonine metabolism of the fox tapeworm Echinococcus multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, online, CH, Nov. 4/5, 2020.
  48. Jebbawi F, Bellanger A-P, Lunström-Stadelmann B, Rufener R, Dosch M, Goepfert C, Gottstein B, Millon L, Grandgirard D, Leib SL, Beldi G, Wang J. Innate and adaptive immune responses following PD-L1 immune checkpoint blockade in treating chronic murine alveolar echinococcosis. 14th World Immune Regulation Meeting (WIRM), Davos (online), CH, Oct. 4-8, 2020.
  49. Rufener, R. Fighting against Echinococcus multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Schwarzenberg, CH, Nov. 14-15, 2019.
  50. Ritler D, Rufener R, Li J, Serricchio M, Kämpfer U, Bühr C, Schürch S, Bütikofer P, Lundström-Stadelmann B. Identification of novel drug targets in Echinococcus multilocularis by metabolomics. Joint annual meeting 2019 SGI / SGInf / SGSH / SGTP / SGTRM, Lausanne, CH, Sept. 18-20, 2019. (P)
  51. Jebbawi, F., Bellanger, A., Lundström-Stadelmann, B., Rufener, R., Dosch, M., Belid, G., Millon, L., Gottstein, B., Wang, J. Innate and adaptive immunity interactions following PD-1/PDL-1 immune checkpoint blockade in murine alveolar echinococcosis. Joint annual meeting 2019 SGI / SGInf / SGSH / SGTP / SGTRM, Lausanne, CH, Sept. 18-20, 2019.
  52. Feucherolles, M., Poppert, S., Endriss, Y., Marti, H., Hermosilla, C., Lundström-Stadelmann, B., Utzinger, J., Becker, S.L. Application of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry in diagnostic helminthology: a proof-of-concept study. Conference on Tropical Medicine and Global Health, Munich, DEU, Apr. 4 -6, 2019.
  53. Rufener, R., Zurbriggen, R., Dick, L., Ritler, D., Hemphill, A., Lundström-Stadelmann, B. Screening of the MMV Pathogen Box reveals the cytochrome bc1 complex as a drug target in Echinococcus multilocularis. Drug Design and Development Seminar (DDDS), Justus-Liebig Universität Giessen, DEU, Mar. 26-29, 2019.
  54. Ritler, D., Rufener, R., Li, J.V., Lundström-Stadelmann, B. In vitro metabolomic studies on the Echinococcus multilocularis metacestode. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Sigriswil, CH, Nov. 1-2, 2018.
  55. Rufener, R., Dick, L., D’Ascoli, L., Ritler, D., Hizem, A., Wells, T., Hemphill, A., Lundström-Stadelmann, B. Targeting the mitochondrial complex III in Echinococcus multilocularis. Swiss Society of Tropical Medicine and Parasitology Students Meeting, Sigriswil, CH, Nov. 1-2, 2018.
  56. Ritler, D., Rufener, R., Li, J.V., Lundström-Stadelmann, B. In vitro metabolomic studies on the Echinococcus multilocularis metacestode. Joint Annual Meeting 2018 SSI | SSHH | SSTMP | SSTTM. Interlaken, CH, Sept. 13-14, 2018. (P, poster flash)
  57. Rufener, R., Dick, L., Ritler, D., Hemphill, A., Lundström-Stadelmann, B. Echinococcus multilocularis: from drug screenings to the energy metabolism. 28th annual meeting of the German Society of Parasitology, Berlin, DEU, Mar. 21-24, 2018.
  58. Ritler, D., Rufener, R., Li, J., Lundström-Stadelmann, B. Starving a deadly parasite: in vitro metabolomic studies on the Echinococcus multilocularis metacestode. 28th annual meeting of the German Society of Parasitology, Berlin, DEU, Mar. 21-24, 2018.
  59. Hemphill, A., Lundström-Stadelmann, B., Rufener, R., Dick, L., Ritler, D., Gottstein, B. Drugs or immunotherapy: what is best for the future? World Congress in Echinococcosis, Algiers, ALG, Oct. 4-7, 2017.
  60. Rufener, R., Dick, L., Strübig, L., Hemphill, A., Lundström-Stadelmann, B. Screening the pathogen box and repurposing buparvaquone against Echinococcus multilocularis. World Congress in Echinococcosis, Algiers, ALG, Oct. 4-7, 2017.
  61. Ritler, D., Rufener, R., Bouvier, J., Sager, H., Hemphill, A., Lundström-Stadelmann, B. Development of a movement-based in vitro screening for new anti-cestodal compounds. World Congress in Echinococcosis, Algiers, ALG, Oct. 4-7, 2017. (P, poster prize)
  62. Ritler, D., Rufener, R., Bouvier, J., Sager, H., Hemphill, A., Lundström-Stadelmann, B. Motility-based in vitro screening for the identification of new anti-cestodal compounds. Joint annual meeting SSM, SSI, SSHH, SSTMP and SSTTM, Basel, CH, Aug. 30 – Sept. 1, 2017. (P)
  63. Rufener, R., Kunz, S., Ritler, D., Hemphill, A., Lundström-Stadelmann, B. Drugs against alveolar echinococcosis: New faces and old friends. Joint annual meeting SSM, SSI, SSHH, SSTMP and SSTTM, Basel, CH, Aug. 30 – Sept. 1, 2017. (P)
  64. Ma’ayeh, S.Y, Stadelmann, B., Knörr, L., Sköld, K., Hoeppner, M., Grabherr, M. and S. G. Svärd. Transcriptional Profiling of Differentiated CaCo-2 Intestinal Epithelial Cells Response to Giardia Intestinalis during Early Onset of in vitro Interactions: Insights into the Pathways of Cytokine Production and Regulation. VI International Giardia and Cryptosporidium Conference, Havana City, CUBA, Apr. 26 – 28, 2017.
  65. Liu, J., Peirasmaki, D., Ma’ayeh, S., Stadelmann, B., Hellman, L. and S. Svärd. Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines. VI International Giardia and Cryptosporidium Conference, Havana City, CUBA, Apr. 26 – 28, 2017. (P)
  66. Peirasmaki, D., Ferella, M., Höppner, M., Campos, S., Ankarklev, J., Stadelmann, B., Grabherr, M. and S. Svärd. High Cysteine Membrane Proteins are highly up-regulated during Giardia-host cell interactions. VI International Giardia and Cryptosporidium Conference, Havana City, CUBA, Apr. 26 – 28, 2017. (P)
  67. Rufener, R., Strübig, L., Ritler, D., Hemphill, A. and B. Lundström-Stadelmann. Drugs against alveolar echinococcosis: the hunt goes on. Joint annual meeting SSI, SSHH, SSTMP and FMH, Montreux, CH, Sept. 1-2, 2016. (P)
  68. Ritler, D., Rufener, R., Bouvier, J., Sager, H., Hemphill, A. and B. Lundström-Stadelmann. Development of a movement-based in vitro screening for new anti-cestodal compounds. Joint annual meeting SSI, SSHH, SSTMP and FMH, Montreux, CH, Sept. 1-2, 2016. (P)
  69. Rufener, R., Aeschbacher, D., Hemphill, A., Stadelmann, B. Focus on anti-malarials for the treatment of alveolar echinococcosis: a new drug on the horizon? COST Action 1307: Chemotherapy Towards Diseases Caused by Endoparasites. Meeting of Working Groups 1 and 4. Porto, May 5-6, 2016 (P).
  70. Hemphill, A., Rufener, R., Stadelmann, B.: Screening of the Open Source malariabox reveals novel potential drug candidate for the treatment of alveolar echinococcosis. 27th meeting of the German Society for Parasitology, Göttingen, Mar. 9-12, 2016.
  71. Rufener, R., Aeschbacher, D., Hemphill, A. and B. Stadelmann. Focus on an anti-malarial drug against Echinococcus multilocularis - a new treatment on the horizon? Joint meeting DGP und SGTP. Zürich, CH, Jul. 16-19, 2014. (P)
  72. Spiliotis, M., Stadelmann, B., Boubaker, G., Hirsch, P., Gottstein, B. and A. Hemphill. Axenic culture of Echinococcus multilocularis primary cells: a novel tool to carry out high-throughput screening assays on bioactive molecules. Joint meeting DGP und SGTP. Zürich, CH, Jul. 16-19, 2014. (P)
  73. Ma'ayeh1, S., Stadelmann1, B., Molin, E., Hoeppner, M., Eteti, C., Andersson, M., Ankarklev, J., Zemani, N., Grabherr, M. and S. Svärd. Transcriptional profiling of differentiated Caco-2 intestinal epithelial cells response to Giardia intestinalis during early onset of in vitro interactions: insights into the pathways of cytokine production and regulation. V International Giardia and Cryptosporidium Conference, Uppsala, SWE, May 27-30, 2014. (P)
  74. Spiliotis, M., Stadelmann, B., Hirschi, P., Gottstein, B. and A. Hemphill. Axenic culture of Echinococcus multilocularis primary cells: a novel tool to carry out high-throughput screening assays on bioactive molecules. Innovation for the Management of Echinococcosis. Besançon, FRA, Mar. 27-29, 2014. (P)